机译:补体受体1是恶性疟原虫PfRh4入侵配体的宿主红细胞受体
The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnThe Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnThe Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnSchools of Chemistry and Biological Sciences, University of Edinburgh, Edinburgh EH9 3JJ, United Kingdom;
rnSchools of Chemistry and Biological Sciences, University of Edinburgh, Edinburgh EH9 3JJ, United Kingdom Department of Microbiology, University of Ghana Medical School, Accra, Ghana;
rnSchools of Chemistry and Biological Sciences, University of Edinburgh, Edinburgh EH9 3JJ, United Kingdom;
rnThe Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnThe Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnThe Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia Department of Medical Biology, University of Melbourne, Parkville 3052, Australia;
rnThe Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia Department of Medical Biology, University of Melbourne, Parkville 3052, Australia;
malaria; red blood cell; merozoite; reticulocyte-binding-like homologue;
机译:恶性疟原虫田间分离株使用补体受体1(CR1)作为入侵红细胞的受体。
机译:恶性疟原虫裂殖子蛋白PfRh4与补体受体1的结合通过调节与C3转化酶片段Bb的相互作用来削弱衰变加速活性。
机译:恶性疟原虫利用补体受体1型中的关键功能位点入侵人的红细胞。
机译:疟疾肽模拟物的抗体抑制疟原虫侵袭红细胞的侵袭
机译:评估PFRH5遗传多样性对疟原虫疟原虫侵袭途径利用的功能影响
机译:补体受体1是恶性疟原虫PfRh4入侵配体的宿主红细胞受体
机译:补体受体1是恶性疟原虫PfRh4入侵配体的宿主红细胞受体
机译:补体受体1是恶性疟原虫的唾液酸非依赖性红细胞受体